Product Name | MF | CAS | Details |
---|
Metronidazole Impurity20 | C6H7N3O4 | 16230-87-8 | Details |
Duloxetine EP Impurity G | C10H7F | 321-38-0 | Details |
L-Valine methyl ester hydrochloride | C6H13NO2.ClH | 6306-52-1 | Details |
Pomalidomide Impurity 15 | C25H31F3N4O11 | 1957236-21-3 | Details |
Iopromide EP Impurity G(Mixture of Diastereomers) | C18H23ClI3N3O7 | 154361-53-2 | Details |
Valsartan N2-Trityl Impurity | Details |
Iopromide Impurity 6 | C18H24I3N3O8 | 73334-07-3 | Details |
Duloxetine EP Impurity C(HBr) | C18H20BrNOS | 949096-01-9 | Details |
Pomalidomide Impurity 17 | C13H9FN2O4 | 835616-60-9 | Details |
(S)-Pomalidomide | C13H11N3O4 | 202271-89-4 | Details |
Lurasidone Metabolite02 | Details |
lurasidone impurity37 | C19H29ClN4S | 1260025-93-1 | Details |
lurasidone impurity11 | C8H16O3S | 14100-97-1 | Details |
Valsartan Impurity 4 | C18H21N5 | 1266616-11-8 | Details |
Pomalidomide Impurity 1 | C16H10N2O6 | 92792-46-6 | Details |
Valsartan Benzyl Ester N1-Trityl Analog | Details |
lurasidone impurity26 | C10H20O6S2 | 186204-35-3 | Details |
5-Hydroxy-6-methoxy duloxetine sulfate | C19H21NO6S2 | 732983-57-2 | Details |
Metronidazole EP Impurity F | C8H13N3O4 | 16156-94-8 | Details |
Metronidazole Impurity15 | C5H6O5 | 542-05-2 | Details |
Metronidazole Impurity 3 | C13H13N3O4 | 87009-72-1 | Details |
lurasidone impurity9 | C8H15ClO | 1932552-08-3 | Details |
lurasidone impurity16 | C28H36N4O2S | 1318074-25-7 | Details |
Valsartan Impurity 10 | C23H29N5O | 1314799-74-0 | Details |
Metronidazole Impurity2 | C13H13N3O4 | 13182-89-3 | Details |
Valsartan Impurity 9 | C25H30N2O3 | 137863-90-2 | Details |
Valsartan Impurity 1 | C13H8BrN | 168072-17-1 | Details |
Duloxetine Impurity 7 | C15H17NO2S2 | 763079-11-4 | Details |
Lurasidone Oxidation Impurities | Details |
lurasidone impurity22 | C28H37ClN4O2S | 139563-24-9 | Details |
Pomalidomide Impurity 6 | C21H14N4O6 | 1795373-54-4 | Details |
lurasidone impurity1 | C18H16N4S2 | 223586-82-1 | Details |
(S)-Duloxetine Phthalamide | C26H23NO4S | 199191-67-8 | Details |
lurasidone impurity29 | C10H20O6S2 | 66347-68-0 | Details |
Duloxetine Impurity 18 | C9H15NOS | 116817-84-6 | Details |
Duloxetine Impurity8 | C9H14ClNOS | 5424-47-5 | Details |
lurasidone impurity18 | C28H36N4O2S | 1318074-24-6 | Details |
Isoleucine Valsartan | C25H31N5O3 | 137862-78-3 | Details |
Pomalidomide Impurity 5 | C13H9N3O6 | 19171-18-7 | Details |
Pomalidomide Impurity 2 | C8H5NO6 | 603-11-2 | Details |
Hydroxy Metronidazole | C6H9N3O4 | 4812-40-2 | Details |
rac-Valsartan Ethyl Ester | C26H33N5O3 | 1894176-41-0 | Details |
Valsartan N1-Trityl Impurity | Details |
lurasidone impurity20 | C19H26N4O3S2 | 186204-37-5 | Details |
Metronidazole EP Impurity D | C5H7N3O3 | 5006-68-8 | Details |
lurasidone impurity40 | C28H37ClN4O2S | 139563-25-0 | Details |
lurasidone impurity25 | C28H36N4O2S | 1448443-35-3 | Details |
Valsartan Ethyl Ester | C26H33N5O3 | 1111177-30-0 | Details |
Lurasidone N-Oxide | Details |
Iopromide EP Impurity E(Mixture of Diastereomers) | C32H37I6N5O14 | 154397-78-1 | Details |
4-Hydroxy Valsartan | C24H29N5O4 | 188259-69-0 | Details |
Duloxetine Impurity 10 | C18H19NOS | 1346599-09-4 | Details |
Metronidazole EP Impurity E | C6H9N3O3 | 705-19-1 | Details |
Valsartan Benzyl Ester N2-Trityl Analog | C50H49N5O3 | 2459446-33-2 | Details |
Pomalidomide Impurity 21 | C21H25F3N4O6 | 2093386-51-5 | Details |
Pomalidomide Impurity 11 | C13H11N3O5 | 1547162-41-3 | Details |
lurasidone impurity32 | C28H36N4O2S | 1318074-19-9 | Details |
Iopromide EP Impurity H | C14H15I3N2O7 | 185459-57-8 | Details |
Pomalidomide Impurity 16 | C25H31F3N4O8 | 1950635-16-1 | Details |
Valsartan Impurity 18 | C14H10N4O2 | 164265-78-5 | Details |
lurasidone impurity8 | C8H14Cl2 | 1416975-23-9 | Details |
Valsartan Impurity 11 | C11H21NO3 | 1189547-11-2 | Details |
Valsartan EP Impurity B | C31H35N5O3 | 137863-20-8 | Details |
Valsartan Impurity 3 Sodium Salt | C14H11N4NaO | 920034-07-7 | Details |
Pomalidomide Impurity 30 | C13H13N3O5 | 1001852-14-7 | Details |
Iopromide EP Impurity F(Mixture of Diastereomers) | C21H28I3N3O9 | 154361-54-3 | Details |
Pomalidomide Impurity 4 | C5H10N2O3 | 585-21-7 | Details |
Valsartan N-Oxide | Details |
Pomalidomide Impurity 19 | C18H19F3N4O6 | 2093388-21-5 | Details |
Pomalidomide Impurity 9 | C13H13N3O5 | 1001852-15-8 | Details |
Valsartan Impurity 8 | C20H22N2O2 | 137863-89-9 | Details |
lurasidone impurity14 | C12H15N3O2S2 | 2190680-18-1 | Details |
Duloxetine Impurity 17 | C9H15NOS | 132335-44-5 | Details |
Iopromide Impurity 2 | C26H30I3N3O12 | 102275-80-9 | Details |
Duloxetine EP Impurity E | C18H19NOS | 1033803-59-6 | Details |
lurasidone impurity30 | C28H36N4O2S | 139505-45-6 | Details |
Iopromide EP Impurity A | C15H20I3N3O6 | 154361-51-0 | Details |
Valsartan Methyl Ester | C25H31N5O3 | 137863-17-3 | Details |
Valsartan EP Impurity A | C24H29N5O3 | 137862-87-4 | Details |
lurasidone impurity27 | C28H36N4O2S | 1318074-18-8 | Details |
Valsartan EP Impurity C | C23H27N5O3 | 952652-79-8 | Details |
Iopromide Impurity 11 | C18H26IN3O8 | 1648627-33-1 | Details |
Duloxetine Impurity 13 | C21H23NO5S | 932013-45-1 | Details |
lurasidone impurity6 | C8H12 | 2819-48-9 | Details |
Pomalidomide Impurity 18 | C17H17F3N4O6 | 1957235-67-4 | Details |
Metronidazole Impurity8 | C6H9N3O3 | 113385-77-6 | Details |
Lurasidone Sulfoxide | C28H36N4O3S | 1809325-45-8 | Details |
Duloxetine Impurity 12 | C21H23NO5S | 116817-26-6 | Details |
Pomalidomide Impurity 31 | C8H7NO5 | 202262-76-8 | Details |
Lurasidone Metabolite01 | Details |
Product Total: Product Page: | ||||
26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 |